Digital Asset
Intelligence
Theme

Search 3CBlock

News, exchanges, regulatory intelligence, reviews and Voices.

Palmer Luckey Discloses SLAB: A Proposed Offshore Platform for Industry and Unregulated Medicine

Add us on Google

Summary: Oculus founder Palmer Luckey revealed plans for SLAB, a seastead designed to operate outside U.S. state regulations. The project aims to host heavy industry and provide access to medicines currently illegal in the United States, though legal and regulatory hurdles remain significant.

Crypto editorial illustration by 3CBlock
Illustration: 3CBlock

Palmer Luckey, the billionaire founder of Oculus and defense technology company Anduril, has publicly revealed details of a long-secret offshore infrastructure project called SLAB. In a post on X published on November 18, 2026, Luckey described the initiative as a proposed seastead with a 1,000-year design life intended to allow American industries to operate outside certain state and local regulations Original reporting. The announcement marks the first public disclosure of the project, which Luckey stated has been in development for nearly a decade.

Project Scope and Funding

Luckey outlined an ambitious vision for SLAB, positioning it as an industrial base capable of supporting sectors such as metal processing, oil refining, medical research, and treatment. He argued that the platform would be cheaper than land-based operations and free from what he characterized as outdated state and local laws that "cripple critical American industries." Luckey framed the project not as an escape from the United States, but as a "relief valve" designed to strengthen the nation by bypassing regulatory bottlenecks.

Regarding financing, Luckey stated that he and a small group of associates secured funding for the project at a $1 billion valuation in 2017, using proceeds from Facebook’s 2014 acquisition of Oculus. "Me and a few close friends cashed it up at a $1B valuation back in 2017, and while it still has a long way to go, there has been significant progress towards my goal of reviving manifest destiny and westward expansion," he wrote Original reporting. Despite these claims, Luckey has not disclosed the project's specific location, current construction status, or an operating timeline. The public reveal included an AI-generated illustration of a massive offshore platform rather than photographs of any existing physical facility.

Access to 'Illegal' Medicine

A central and controversial component of Luckey’s proposal involves medical treatments. In a heated exchange with journalist Joshua Topolsky on X, Luckey indicated that one of his primary goals is to enable access to medicines that are currently illegal in the United States. When challenged on whether building an offshore community was a sensible approach to modernizing medical research, Luckey responded that he would rather build a place where people could save their families with "safe but currently illegal medicine ASAP" than wait for legislative reform Original reporting.

Luckey accused political interests and large pharmaceutical companies of obstructing change, arguing that conventional regulatory reform would require legislation capable of securing support from 60 senators in the U.S. Senate. This stance raises significant questions about the intersection of offshore autonomy and U.S. drug laws.

Legal and Jurisdictional Complexities

The feasibility of operating outside U.S. law faces substantial legal complications. When asked how close SLAB could operate to San Francisco without falling under its jurisdiction, Luckey answered, "Three miles." This distance generally corresponds to the boundary of California's state-controlled coastal waters, according to the U.S. Bureau of Ocean Energy Management. However, federal jurisdiction extends considerably farther. The United States maintains a 12-nautical-mile territorial sea and a 200-nautical-mile exclusive economic zone, where it retains authority over certain economic activities and the construction of artificial islands, according to NOAA guidance.

Furthermore, medical research conducted offshore does not automatically exempt practitioners from U.S. regulatory standards if they intend to serve the American market. The FDA requires foreign clinical studies submitted in support of U.S. drug approvals to meet good clinical practice standards, including independent ethical review and informed consent. Conducting treatment offshore would not, by itself, make an unapproved drug legal for sale in the United States. Previous seasteading experiments, such as a floating community off Thailand in 2019, have encountered similar jurisdictional disputes with national authorities.

Luckey stated he decided to disclose SLAB after learning that journalists were preparing to describe it merely as a floating AI data center, a characterization he rejected as incomplete. As of now, the project remains a conceptual proposal with no independently verifiable details regarding its physical development or regulatory strategy.